Portland, OR, Dec. 01, 2020 – The global 3D Printing Healthcare Market generated $972.6 million in 2018 and is expected to generate $3.69 billion by 2026, registering a CAGR of 18.2% from 2019 to 2027. The recent success in 3D printing of tablets has opened new avenues for use of 3D printing technology in the pharmaceutical industry. Research & development activities, on the other hand, in 3D printing healthcare has been increased during the global lockdown, owing to fulfill the demand in health care services. High cost associated with 3D printers, copyright & patent infringement concerns, lack of quality & regulatory frameworks for 3D printers, reimbursement challenges, and concerns regarding mechanical properties & biocompatibility are the key factors responsible for hampering the market growth. Based on application, the external wearable devices segment held nearly three-fifths of the total share in terms of revenue of the global 3D printing healthcare market in 2018, and will maintain its dominance by 2026. Based on component, the system segment accounted for the highest market share in the global 3D printing healthcare market in 2018, contributing to more than half of the total share, and is estimated to maintain its leadership status during the forecast period. Allied Market Research is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon.
Read the full article at GlobeNewswire News Room
